Skip to main content
logo
Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
5.84
-0.35 (-5.65%)
At close: Mar 12, 2026, 4:00 PM EDT
5.91
+0.07 (1.20%)
After-hours: Mar 12, 2026, 4:48 PM EDT

Verastem Revenue

In the year 2025, Verastem had annual revenue of $30.91M with 209.14% growth. Verastem had revenue of $17.54M in the quarter ending December 31, 2025.

Revenue (ttm)
$30.91M
Revenue Growth
+209.14%
P/S Ratio
17.09
Revenue / Employee
$303,078
Employees
102
Market Cap
512.96M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202530.91M20.91M209.14%
Dec 31, 202410.00M--
Dec 31, 2023---
Dec 31, 20222.60M543.00K26.45%
Dec 31, 20212.05M-86.46M-97.68%
Dec 31, 202088.52M71.06M407.08%
Dec 31, 201917.46M-9.26M-34.67%
Dec 31, 201826.72M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CorMedix311.71M
Vanda Pharmaceuticals216.11M
Fulcrum Therapeutics80.00M
Invivyd53.43M
Prothena Corporation9.68M
YD Bio510.36K
Lyell Immunopharma41.00K
Revenue Rankings

VSTM News

More News